S. Guruswamy

发表

EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells.

G. Elberg, Dorit Elberg, T. Lewis, 2007, American journal of physiology. Renal physiology.

Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.

K. Berlin, M. Birrer, S. Guruswamy, 2004, Journal of Medicinal Chemistry.

Retinoids Chemosensitize Ovarian Cancer Cell Lines to Cisplatin Independent of Nuclear Receptors and p53

S. Guruswamy, D. Benbrook, 2006 .

EP 2 receptor mediates PGE 2-induced cystogenesis of human renal epithelial cells

G. Elberg, Dorit Elberg, T. Lewis, 2007 .

1 EP 2 Receptor Mediates PGE 2-Induced Cystogenesis of Human Renal Epithelial Cells

G. Elberg, Dorit Elberg, T. Lewis, 2007 .

Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures

G. Elberg, S. Guruswamy, Lijuan Chen, 2008, Cell and Tissue Research.

Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.

K. Berlin, S. Lightfoot, S. Guruswamy, 2001, Journal of the National Cancer Institute.

Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention.

C. Rao, S. Guruswamy, 2009, International journal of oncology.

Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes.

S. Guruswamy, J. Pessin, A. Olson, 1998, The Journal of biological chemistry.

Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists

K. Berlin, S. Lightfoot, S. Guruswamy, 2005, Investigational New Drugs.

Sensitization of cervical cancer cell lines to low-dose radiation by retinoic acid does not require functional p53.

S. Guruswamy, T. Tillmanns, D. Benbrook, 2005, Gynecologic oncology.

Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.

V. Steele, L. Kopelovich, C. Rao, 2009, Cancer research.

Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling

C. Rao, S. Guruswamy, 2008, Gene regulation and systems biology.

S‐adenosyl L‐methionine inhibits azoxymethane‐induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco‐2 cell growth in 3D culture

V. Steele, C. Rao, S. Guruswamy, 2008, International journal of cancer.

The effects of licofelone, a dual lipoxygenase and cyclooxygenase inhibitor, with and without rosiglitazone in human MCF-7 and MDA-MB-231 breast cancer cells

C. Rao, S. Guruswamy, H. Ozer, 2007 .

Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCmin/+ Mice By SHetA2 (NSC721689) without Toxicity

Yuhong Wang, C. Rao, Yuting Zhang, 2013, Cancer Prevention Research.

Myocyte Enhancer Factor 2 (MEF2)-Binding Site Is Required forGLUT4 Gene Expression in Transgenic Mice

S. Guruswamy, J. Pessin, A. Olson, 1998, The Journal of Biological Chemistry.

Ovarian cancer metastatic to the brain: What is the optimal management?

S. Guruswamy, R. Mannel, T. Tillmanns, 2001, Journal of surgical oncology.